CALCOCO2

Calcium-binding and coiled-coil domain-containing protein 2 · Q13137 · CALCOCO2 on Sugi Atlas →

0 patent compounds predicted against CALCOCO2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CALCOCO2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Bioequivalence Study of Tacrolimus in Healthy Volunteers PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Parathyroid Hormone (PTH) Homeostasis in Bartter Syndrome nanUNKNOWN
Assessing Bone Calcium Content in Children With Kidney Disease Treated With Two Different Medicines nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Familial Intracranial Aneurysm Study II nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Joint Determinants of Bone Density and CVD Calcification nanCOMPLETED
Stone Centre Urine and Serum Bank nanUNKNOWN
S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis nanCOMPLETED
Stone Disease in Children and Their Families nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Corpus Callosum Agenesis and Intellectual Disability nanCOMPLETED
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING
Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma nanRECRUITING
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2) nanUNKNOWN
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism nanUNKNOWN
Human Epilepsy Genetics--Neuronal Migration Disorders Study nanRECRUITING
Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) nanRECRUITING
Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CALCOCO2 binder may also engage these)

ProteinNameSimilarity
Q5R7H1 1.000 Q5R7H1 →
Q4R914 0.997 Q4R914 →
O18737 0.996 O18737 →
Q3URD3 0.982 Q3URD3 →
Q5R4U3 0.979 Q5R4U3 →
Q2KJE0 0.979 Q2KJE0 →
P0C219 0.978 P0C219 →
Q86VP1 0.977 Q86VP1 →
Q66HA4 0.976 Q66HA4 →
P97817 0.976 P97817 →
Q14BN4 0.976 Q14BN4 →
Q3UKC1 0.974 Q3UKC1 →
Q28623 0.974 Q28623 →
A0PJP4 0.971 A0PJP4 →
Q4R3X1 0.970 Q4R3X1 →
Q4KLN4 0.969 Q4KLN4 →
Q17QT2 0.969 Q17QT2 →
AZI2 5-azacytidine-induced protein 2 0.969 landscape →
Q7TPQ3 0.969 Q7TPQ3 →
Q96KN7 0.969 Q96KN7 →
CDR2 Cerebellar degeneration-related protein 2 0.968 landscape →
Q8IZC4 0.967 Q8IZC4 →
Q8CG73 0.967 Q8CG73 →
Q9GLM3 0.967 Q9GLM3 →
Q7ZYB4 0.967 Q7ZYB4 →
Q69Z66 0.967 Q69Z66 →
Q17QG3 0.966 Q17QG3 →
Q5XIX3 0.966 Q5XIX3 →
Q2HJ90 0.966 Q2HJ90 →
Q5ZJA3 0.966 Q5ZJA3 →